Changchun High-tech (000661.SZ): GenSci134 injection clinical trial application approved.

China Fortune Financial News APP, Changchun High-tech (000661.SZ) announced that its subsidiary, Changchun Goldstar Pharmaceutical Co., Ltd. ("Goldstar Pharmaceuticals"), recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. The domestic production drug registration clinical trial application for GenSci134 injection of Goldstar Pharmaceuticals has been approved.